Induced Pluripotent Stem Cells Market: Trends, Innovations and Competitive Analysis
25. November 2024 06:57 ET
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells Market" report has been added to ResearchAndMarkets.com's offering.The Induced Pluripotent Stem Cells Market was valued...
Induced Pluripotent Stem Cells Market Forecast: Comprehensive Global Analysis 2023-2028
12. Januar 2024 05:38 ET
|
Research and Markets
Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. A groundbreaking research...
Clinical Trials Using iPSCs for Heart Diseases, Stroke, and Cancer Treatment Propel Induced Pluripotent Stem Cell Market Growth
08. November 2023 07:53 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Global Induced Pluripotent Stem Cell Market Report 2023: Cost-effective Benefits of iPSC for Drug Discovery Drive Growth
05. Mai 2023 06:53 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering. ...
Induced Pluripotent Stem Cells Production Global Market Report 2022: Use Of IPSCs In Regenerative Medicine Presents Opportunities
05. Januar 2023 07:33 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Cell Culture), By Product, By...
Induced Pluripotent Stem Cell (iPSC) Global Market to Reach $3.57 Billion by 2026
01. August 2022 05:13 ET
|
Research and Markets
Dublin, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022, By Derived Cell Type, By Application, By End-User" report has been added to...
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand
13. April 2021 06:13 ET
|
Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021" report has been added to ResearchAndMarkets.com's offering. The main...
Global Stem Cell Partnering Terms and Agreements Directory 2020: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target & Technology Type
05. Februar 2021 07:13 ET
|
Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Stem Cell Partnering Terms and Agreements 2010-2020" report has been added to ResearchAndMarkets.com's offering. The Global Stem Cell Partnering...
Q Therapeutics Announces Joint Venture With REPROCELL
23. April 2018 05:00 ET
|
Q Therapeutics, Inc.
PARTNERSHIP WILL DEVELOP IPSC-DERIVED PRODUCTS TO TREAT CENTRAL NERVOUS SYSTEM DISEASES INVOLVING DEMYELINATION AND DEGENERATIONSALT LAKE CITY and YOKOHAMA, Japan, April 23, 2018 (GLOBE NEWSWIRE) --...
Q Therapeutics Announces Research Collaboration With REPROCELL
13. Dezember 2017 07:00 ET
|
Q Therapeutics, Inc.
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury,...